Tecentriq and Glimepiride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tecentriq (atezolizumab) and Glimepiride (glimepiride). Common drug interactions include anxiety among females and c-reactive protein increased among males.

The phase IV clinical study analyzes what interactions people have when they take Tecentriq and Glimepiride. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tecentriq?

Tecentriq has active ingredients of atezolizumab. eHealthMe is studying from 12,796 Tecentriq users. Check the latest studies of Tecentriq.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

On Aug, 01, 2026

20 people who take Tecentriq and Glimepiride together, and have interactions are studied.

Tecentriq and Glimepiride drug interactions.

What are the common drug interactions of Tecentriq and Glimepiride, by gender? *:

female:

Anxiety
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
Death
Hepatitis (inflammation of the liver)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Small cell lung cancer (small cell cancer tumour of lung)

male:

C-reactive protein increased
Cytomegalovirus infection
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Biliary tract disorder
Colitis (inflammation of colon)
Hepatic infection
Alanine aminotransferase increased
Arthralgia (joint pain)

What are the common drug interactions of Tecentriq and Glimepiride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alanine aminotransferase increased
Aspartate aminotransferase increased

50-59:

Cholangitis (infection of the bile duct)

60+:

Arthralgia (joint pain)
Anxiety
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Hepatic failure (liver failure)
Hyperglycaemic hyperosmolar nonketotic syndrome (too much sugar (glucose) in your blood)
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
White blood cell count increased
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Hepatocellular Carcinoma (liver cancer): 8 people, 40.00%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 15.00%
White Blood Cell Count Increased: 2 people, 10.00%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 2 people, 10.00%
Lung Cancer - Small Cell (lung cancer): 2 people, 10.00%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 10.00%
Type 2 Diabetes: 1 person, 5.00%
Pain: 1 person, 5.00%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.00%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tecentriq and Glimepiride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously